Accessibility Menu
Ultralife logo

Ultralife(NASDAQ) ULBI

Market Cap$85.95MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1992)-60%
5 Year-35%
1 Year-37%
1 Month-18%
$5.22
-1.51%
-0.08Today
Ultralife last closing stock price
MetricPriceDate
Last closeUSD 5.162026-07-30
Ultralife stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-4.09%USD 5.382026-07-23
1 month-18.35%USD 6.322026-06-30
3 month-24.78%USD 6.862026-05-01
Year to date-9.79%USD 5.722025-12-31
1 year-37.15%USD 8.212025-07-30
3 year-37%USD 8.192023-07-31
5 year-35.01%USD 7.942021-07-30
Since inception-60%USD 13.251992-12-23

Ultralife Financials at a Glance

Market Cap

$85.95MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$187.86M

Net Income (TTM)

-$8.21M

EPS (TTM)

-$0.49

P/E Ratio

-10.46

Dividend

$0.00

Beta (Volatility)

0.96 (Low)

Price

$5.22

Volume

40,458

Open

$5.26

Previous Close

$5.16

Daily Range

$5.16 - $5.39

52-Week Range

$4.90 - $8.72

Estimated Earnings Date

Jul 30, 2026

ULBI News

Foolcom-Featured.png

Ultralife (ULBI) Q2 Revenue Rises 13%

Motley Fool Markets TeamAug 7, 2025

5 Stocks Bouncing Back

Rich DupreyMar 25, 2010

Today's 5-Star Movers

Motley Fool StaffMay 29, 2008

More Than Momentum: Stocks Rising for a Reason

Dave MockJan 9, 2008

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Ultralife

Ultralife makes batteries and communication systems for defense, industry, and consumers. Its batteries power devices in hospitals, oil fields, and military equipment. Communication products help soldiers and emergency teams stay connected in tough conditions.

Powering Up: What Ultralife Sells

  • Battery & Energy Products (93.1% of revenue): Non-rechargeable and rechargeable batteries for medical, industrial, and military devices.
  • Battery Charging Systems: Smart chargers and accessories for commercial and defense users.
  • Uninterruptable Power Supplies: Backup power systems for critical equipment in hospitals and industry.
  • Communications Systems (6.9% of revenue): Military radio accessories, amplifiers, and rugged communication gear for defense and emergency services.
  • Consumer 9-Volt Batteries: Sold through retail and online channels for everyday electronics.

Growth Spurts and Strategic Moves

  • Acquired Excell Battery Group in 2021, expanding into medical and industrial batteries.
  • Bought SWE in 2019, adding oil and gas sector products.
  • Purchased Accutronics in 2016, strengthening European presence and custom battery design.
  • Acquired Electrochem Solutions in October 2024, broadening specialty battery offerings.
  • Rebranded all sub-brands under Ultralife in October 2025 for operational efficiency and clarity.

Why Ultralife Stands Out

Ultralife operates manufacturing and research sites in North America, Europe, and Asia. The company focuses on custom battery solutions for demanding environments. Its customer base includes defense departments, original equipment manufacturers, and commercial clients worldwide.

Five Things You Need to Know

  • Revenue was $191.2 million in 2025, up 16.2% from 2024.
  • Battery & Energy Products made up 93.1% of 2025 revenue.
  • Gross margin fell to 24.1% in 2025, down from 25.7% in 2024.
  • Operating loss was $5.9 million in 2025, versus $10 million income in 2024.
  • Backlog reached $110.2 million at year-end 2025, up 7.9% year-over-year.

Bottom Line

Ultralife has grown through acquisitions and product expansion, serving both defense and commercial markets. The company faces challenges but remains a key supplier of batteries and communication systems worldwide.

AI Generated • Apr 16, 2026

Industry

Electrical Equipment

Sector

Industrials

Employees

678

CEO

Michael Edward Manna

Website

www.ultralifecorporation.com

Headquarters

Newark, NY 14513, US

ULBI Financials

Key Financial Metrics (TTM)

Gross Margin

22.36%

Operating Margin

2.05%

Net Income Margin

-4.37%

Return on Equity

-6.14%

Return on Capital

5.13%

Return on Assets

-3.72%

Earnings Yield

-9.56%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$85.95MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

16.66M

Volume

40.46K

Avg. Volume

42.23K

Financials (TTM)

Gross Profit

$42.01M

Operating Income

$3.85M

EBITDA

-$2.25M

Operating Cash Flow

$9.88M

Capital Expenditure

-$3.75M

Free Cash Flow

$6.13M

Cash & ST Invst.

$8.89M

Total Debt

$47.63M

Ultralife Performance Analysis

Ultralife annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 131,840,00034.2%
20232023-12-31USD 158,644,00020.3%
20242024-12-31USD 164,456,0003.7%
20252025-12-31USD 191,159,00016.2%
Ultralife sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-30-4.3%
Q32025-09-30-10.7%
Q42025-12-3111.8%
Q12026-03-31-2.1%
Ultralife annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -0.01-49.3%
20232023-12-31USD 0.44N/A
20242024-12-31USD 0.38-15.1%
20252025-12-31USD -0.35N/A
Ultralife sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-30-52.0%
Q32025-09-30-238.8%
Q42025-12-31-513.9%
Q12026-03-3194.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$47.45M

-6.5%

Gross Profit

$9.84M

-20.2%

Gross Margin

20.75%

N/A

Market Cap

$85.95MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$126.77K

N/A

Employees

678

N/A

Net Income

-$451.00K

-124.2%

EBITDA

$1.53M

-68.4%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$8.89M

+2.0%

Total Debt

$47.63M

-17.2%

Accounts Receivable

$34.43M

-4.5%

Inventory

$57.29M

+19.7%

Long Term Debt

$44.19M

-17.1%

Short Term Debt

$3.44M

-18.5%

Return on Assets

-3.72%

N/A

Return on Invested Capital

2.17%

N/A

Free Cash Flow

$1.49M

-39.9%

Operating Cash Flow

$2.26M

-33.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
SPAISafe Pro Group Inc. Common Stock
$3.90+5.12%
CBATCBAK Energy Technology, Inc.
$0.50+1.91%
MATHMetalpha Technology Holding Limited
$0.92-0.44%
FLUXFlux Power Holdings, Inc.
$0.54+5.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
INTCIntel
$91.13+0.11%
NVDANvidia
$195.04+0.03%
MSFTMicrosoft
$451.10+0.16%
NOKNokia
$9.09+0.08%

Questions About ULBI

What is the current price of Ultralife?

Ultralife is trading at $5.16 per share.

What is the 52-week range for Ultralife?

Over the past 52 weeks, Ultralife has traded between $4.90 and $8.72.

How much debt does Ultralife have?

As of the most recent reporting period, Ultralife reported total debt of $50.73M.

How much cash does Ultralife have on hand?

Ultralife reported $8.89M in cash and cash equivalents in its most recent financial results.

What is Ultralife’s dividend yield?

Ultralife does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services